首页> 外国专利> Monoclonal anti-human breast cancer antibodies, their production and use, and hybridomas for producing the same and their preparation

Monoclonal anti-human breast cancer antibodies, their production and use, and hybridomas for producing the same and their preparation

机译:单克隆抗人乳腺癌抗体,它们的产生和用途以及用于产生该抗体的杂交瘤及其制备

摘要

Murine monoclonal antibodies are prepared and characterized which bind selectively to human breast cancer cells, are IgGs or IgMs, and when conjugated to ricin A chain, exhibit a TCID 50% against at least one of MCF-7, CAMA-1, SKBR-3, or BT-20 cells of less than about 10 nM. Methods for diagnosing, monitoring, and treating human breast cancer with the antibodies or immunotoxins made therefrom are described.
机译:制备并表征了鼠单克隆抗体,其选择性结合人乳腺癌细胞,为IgG或IgM,并且与蓖麻蛋白A链结合后,对MCF-7,CAMA-1,SKBR-3中的至少一种表现出TCID 50%或小于约10 nM的BT-20细胞。描述了用由此产生的抗体或免疫毒素诊断,监测和治疗人乳腺癌的方法。

著录项

  • 公开/公告号IE58974B1

    专利类型

  • 公开/公告日1993-12-15

    原文格式PDF

  • 申请/专利权人 CETUS ONCOLOGY CORPORATION;

    申请/专利号IE19850000300

  • 发明设计人

    申请日1985-05-07

  • 分类号C12P21/00;C12N5/00;C12N15/00;A61K39/395;G01N33/577;

  • 国家 IE

  • 入库时间 2022-08-22 04:45:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号